Background: Abnormal lipid metabolism and cell oxidative mechanisms are reported in patients on antiretroviral treatment. We compared the expression of several key adipocyte genes in HIV-infected patients randomized to antiretroviral regimens containing zidovudine (AZT) or tenofovir disoproxil fumarate (TDF). Methods: Subcutaneous fat was sampled from 32 HIV-positive treatment-naive patients before and 6 months after randomization to AZT/lamivudine/efavirenz (n=15) or TDF/emtricitabine/efavirenz (n=17) plus 15 HIV-negative matched controls. Expression of genes involved in adipocyte differentiation, lipid metabolism, mitochondrial function and glucocorticoid generation were profiled using real-time PCR. Lipoprotein lipase and hepatic lip...
To compare changes in gene expression by microarray from subcutaneous adipose tissue from HIV treatm...
Background. Treatment of human immunodeficiency virus (HIV)–1 with thymidine-analogue nucleoside rev...
(See the editorial commentary by Hadigan, on pages 1729–31.) Background. Treatment of human immunode...
BACKGROUND: Abnormal lipid metabolism and cell oxidative mechanisms are reported in patients on anti...
BACKGROUND: Antiretroviral (ARV) treatment has been associated with abnormalities in lipid and mitoc...
Background: Antiretroviral (ARV) treatment has been associated with abnormalities in lipid and mitoc...
Data examining the contribution of drug, HIV and host demographic covariates to changes occurring in...
Objectives: To examine the in vivo effects of highly active antiretroviral therapy (HAART) regimens ...
Gene expression studies of subcutaneous adipose tissue may help to better understand the mechanisms ...
Background: Damage to mitochondria (mt) is a major side effect of highly active antiretroviral thera...
BackgroundLong-term use of both zidovudine (AZT) and stavudine (d4T) is associated with lipoatrophy,...
OBJECTIVE:To compare changes in gene expression by microarray from subcutaneous adipose tissue from ...
Lipodystrophy (LD) is a main side effect of antiretroviral therapy for HIV infection, and can be pro...
HIV-1/HAART-associated lipodystrophy syndrome (HALS) has been associated with exposure to stavudine ...
Background. The effect of nonthymidine nucleoside reverse-transcriptase inhibitors (NRTIs) on fat mi...
To compare changes in gene expression by microarray from subcutaneous adipose tissue from HIV treatm...
Background. Treatment of human immunodeficiency virus (HIV)–1 with thymidine-analogue nucleoside rev...
(See the editorial commentary by Hadigan, on pages 1729–31.) Background. Treatment of human immunode...
BACKGROUND: Abnormal lipid metabolism and cell oxidative mechanisms are reported in patients on anti...
BACKGROUND: Antiretroviral (ARV) treatment has been associated with abnormalities in lipid and mitoc...
Background: Antiretroviral (ARV) treatment has been associated with abnormalities in lipid and mitoc...
Data examining the contribution of drug, HIV and host demographic covariates to changes occurring in...
Objectives: To examine the in vivo effects of highly active antiretroviral therapy (HAART) regimens ...
Gene expression studies of subcutaneous adipose tissue may help to better understand the mechanisms ...
Background: Damage to mitochondria (mt) is a major side effect of highly active antiretroviral thera...
BackgroundLong-term use of both zidovudine (AZT) and stavudine (d4T) is associated with lipoatrophy,...
OBJECTIVE:To compare changes in gene expression by microarray from subcutaneous adipose tissue from ...
Lipodystrophy (LD) is a main side effect of antiretroviral therapy for HIV infection, and can be pro...
HIV-1/HAART-associated lipodystrophy syndrome (HALS) has been associated with exposure to stavudine ...
Background. The effect of nonthymidine nucleoside reverse-transcriptase inhibitors (NRTIs) on fat mi...
To compare changes in gene expression by microarray from subcutaneous adipose tissue from HIV treatm...
Background. Treatment of human immunodeficiency virus (HIV)–1 with thymidine-analogue nucleoside rev...
(See the editorial commentary by Hadigan, on pages 1729–31.) Background. Treatment of human immunode...